4//SEC Filing
Sylvain Jereme M 4
Accession 0001093557-24-000040
CIK 0001093557other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 6:32 PM ET
Size
5.2 KB
Accession
0001093557-24-000040
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Sylvain Jereme M
EVP, Chief Financal Officer
Transactions
- Award
Common Stock
2024-03-08+26,053→ 97,195 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 52,009 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,384 of which were granted on December 15, 2021 and shall vest through December 15, 2024.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001681267
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 6:32 PM ET
- Size
- 5.2 KB